Rankings
▼
Calendar
BSX FY 2013 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena
BSX
Boston Scientific Corporation
$103B
FY 2013 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$7.1B
-1.5% YoY
Gross Profit
$4.5B
63.5% margin
Operating Income
$871M
12.2% margin
Net Income
-$121M
-1.7% margin
EPS (Diluted)
$-0.09
Cash Flow
Operating Cash Flow
$1.1B
Free Cash Flow
$837M
Stock-Based Comp.
$105M
Balance Sheet
Total Assets
$16.7B
Total Liabilities
$10.2B
Stockholders' Equity
$6.5B
Cash & Equivalents
$217M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$7.1B
$7.2B
-1.5%
Gross Profit
$4.5B
$4.6B
-0.5%
Operating Income
$871M
$994M
-12.4%
Net Income
-$121M
-$4.1B
+97.0%
← FY 2012
All Quarters
FY 2014 →